Phase 1 lead ‐in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma

Cancer, EarlyView.

Source: Cancer - October 25, 2018 Category: Cancer & Oncology Authors: Stefania Maraka, Morris D. Groves, Aaron G. Mammoser, Isaac Melguizo ‐Gavilanes, Charles A. Conrad, Ivo W. Tremont‐Lukats, Monica E. Loghin, Barbara J. O’Brien, Vinay K. Puduvalli, Erik P. Sulman, Kenneth R. Hess, Kenneth D. Aldape, Mark Source Type: research